Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial

pharmaceutical-technologyJune 30, 2020

Tag: gilead , Remdesivir , COVID-19

PharmaSources Customer Service